LONDON PHARM NETWORK LIMITED

Company Registration Number:
14821616 (England and Wales)

Unaudited statutory accounts for the year ended 30 April 2024

Period of accounts

Start date: 24 April 2023

End date: 30 April 2024

LONDON PHARM NETWORK LIMITED

Contents of the Financial Statements

for the Period Ended 30 April 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 12

LONDON PHARM NETWORK LIMITED

Company Information

for the Period Ended 30 April 2024




Director: MICAH ANIAKOR
Registered office: 101,
700 Woolwich Road
London
England
SE7 8LQ
Company Registration Number: 14821616 (England and Wales)

LONDON PHARM NETWORK LIMITED

Directors' Report Period Ended 30 April 2024

The directors present their report with the financial statements of the company for the period ended 30 April 2024

Directors

The director(s) shown below were appointed to the company during the period
MICAH ANIAKOR
25 April 2023

This report was approved by the board of directors on 4 March 2025
And Signed On Behalf Of The Board By:

Name: MICAH ANIAKOR
Status: Director

LONDON PHARM NETWORK LIMITED

Profit and Loss Account

for the Period Ended 30 April 2024


Notes

2024
£
Turnover 31,473
Cost of sales ( 1,591 )
Gross Profit or (Loss) 29,882
Distribution Costs ( 781 )
Administrative Expenses ( 1,609 )
Operating Profit or (Loss) 27,492
Profit or (Loss) Before Tax 27,492
Tax on Profit ( 5,224 )
Profit or (Loss) for Period 22,268

The notes form part of these financial statements

LONDON PHARM NETWORK LIMITED

Balance sheet

As at 30 April 2024


Notes

2024
£
Fixed assets
Total fixed assets: -
Current assets
Cash at bank and in hand: 26,486
Total current assets: 26,486
Creditors: amounts falling due within one year: 5 ( 5,287 )
Net current assets (liabilities): 21,199
Total assets less current liabilities: 21,199
Accruals and deferred income: ( 636 )
Total net assets (liabilities): 20,563

The notes form part of these financial statements

LONDON PHARM NETWORK LIMITED

Balance sheet continued

As at 30 April 2024


Notes

2024
£
Capital and reserves
Called up share capital: 1
Profit and loss account: 20,562
Shareholders funds: 20,563

For the year ending 30 April 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 4 March 2025
And Signed On Behalf Of The Board By:

Name: MICAH ANIAKOR
Status: Director

The notes form part of these financial statements

LONDON PHARM NETWORK LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

LONDON PHARM NETWORK LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

  • 2. Employees


    2024
    Average number of employees during the period 0

    During this year the average number of employee was 0.

LONDON PHARM NETWORK LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

  • 3. Off balance sheet disclosure

    No

LONDON PHARM NETWORK LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

4. Dividends


2024
£
Dividends paid 500

The sum of £500 was paid to the director as dividends.

LONDON PHARM NETWORK LIMITED

Notes to the Financial Statements

for the Period Ended 30 April 2024

5.Creditors: amounts falling due within one year note


2024
£
Bank loans and overdrafts 500
Taxation and social security 4,151
Accruals and deferred income 636
Total 5,287